Distrobird — Free Sales Engagement Platform

Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.


Journal of Advanced Biotechnology and Experimental Therapeutics

linklinkedinfacebooktwitter

about jabet journal of advanced biotechnology and experimental therapeutics (jabet) – is an open access, international, peer-reviewed, scientific journal publishing original research findings and reviews on all aspects of biotechnology and experimental therapeutics. it provides a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in translational research and recent discoveries in the biotechnology and biomedical sciences. • short name: j adv biotechnol exp ther • electronic issn: 2616-4760 • year of starting: september 2017, first issue- january 2018 • license type: free for non-commercial use (cc-by-nc 4.0), [open access] • country of publication: south korea the vision of our journal is to ‣ upgrade the awareness among experts and the young scientists about modern breakthroughs and emerging opportunities in biotechnology and biomedical research. ‣ establish rapid peer review processes to accelerat

Headquarters:
Seoul, South Korea
Industry:
Publishing
Founded:
2017
Employees:
-
Annual Revenue:
-

Type: Educational
Ticker: -

Frequently asked questions about Journal of Advanced Biotechnology and Experimental Therapeutics

Let us help answer the most common questions you might have.

Where is Journal of Advanced Biotechnology and Experimental Therapeutics located?

angle left

Journal of Advanced Biotechnology and Experimental Therapeutics' headquarters is located at Seoul, South Korea

What is Journal of Advanced Biotechnology and Experimental Therapeutics' official website?

angle left

Journal of Advanced Biotechnology and Experimental Therapeutics' official website is bsmiab.org

What industry does Journal of Advanced Biotechnology and Experimental Therapeutics belong to?

angle left

Journal of Advanced Biotechnology and Experimental Therapeutics is in the industry of: Publishing

What are Journal of Advanced Biotechnology and Experimental Therapeutics' social media links?

angle left

Journal of Advanced Biotechnology and Experimental Therapeutics Linkedin page

Distrobird — Free Sales Engagement Platform

Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.


You’ll be in good company
Calling Distrobird an all-in-one tool is an oversimplification of the value it delivers. All the workflows we need to acquire and support our SMB users across all channels are deeply integrated. I couldn’t be happier with our choice.

Jody Schnarr

CEO of Fibernetics

The #1 reason why we chose Distrobird is because it provides all the building blocks we need to engage our customers in a unified way — From email, texting, telephony and collaboration. This is probably the last tool you’ll buy for lead and customer outreach.

Laurel Palmer

Director, College Fund, Kalamazoo College

Stitching together a bunch of integrations and add-ons across multiple vendors is not my idea of productivity or efficiency. Thats why we chose Distrobird — each module is as full featured as any standalone competition.

Paul Marai

VP Digital Marketing

From Our Blog